Core Insights - Fortive Corporation reported third-quarter 2025 adjusted earnings per share (EPS) of 68 cents, exceeding the Zacks Consensus Estimate of 58 cents, marking a year-over-year increase of 15.3% [1][9] - Revenues for the quarter rose 2.3% year over year to $1.03 billion, surpassing the Zacks Consensus Estimate by 2.1%, with core revenues increasing by 1.9% [1][9] Financial Performance - The company executed $1 billion in share repurchases during the quarter, reflecting its disciplined capital allocation strategy [3] - Fortive raised its full-year 2025 EPS guidance to a range of $2.63 to $2.67, up from the previous estimate of $2.50 to $2.60, due to strong third-quarter performance [4][12] - As of September 26, 2025, cash and cash equivalents were $430.8 million, down from $1,827.4 million as of June 27, 2025 [11] Segment Performance - Intelligent Operating Solutions generated revenues of $698.8 million, contributing 68% to total revenues, with a year-over-year increase of 2.6% [6] - Advanced Healthcare Solutions reported revenues of $328.3 million, accounting for 32% of total revenues, up 1.8% year over year [6] - Adjusted operating margins for Intelligent Operating Solutions were 32.8%, expanding 110 basis points year over year, while Advanced Healthcare Solutions saw adjusted operating margins of 26.7%, rising 130 basis points [10] Outlook - The company anticipates overall core growth to moderate in the fourth quarter, with Advanced Healthcare Solutions core growth expected to remain in line with third-quarter levels [13] - Fortive expects a sequential increase in net interest expense in the fourth quarter and maintains a projected adjusted effective tax rate in the mid-teens for 2025 [13]

Core Insights - Fortive (FTV) reported a revenue of $1.02 billion for the quarter ended June 2025, marking a year-over-year decline of 34.5% and an EPS of $0.58 compared to $0.93 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $1.01 billion by 0.85%, while the EPS fell short of the consensus estimate of $0.60 by 3.33% [1] Financial Performance Metrics - Advanced Healthcare Solutions generated sales of $319.5 million, slightly above the estimated $319.3 million, reflecting a year-over-year decline of 1.3% [4] - Intelligent Operating Solutions reported sales of $675.7 million, below the estimated $689.46 million, with a year-over-year change of -0.2% [4] - Adjusted Operating Profit (Non-GAAP) for Intelligent Operating Solutions was $223.7 million, exceeding the average estimate of $222.26 million [4] - Adjusted Operating Profit (Non-GAAP) for Advanced Healthcare Solutions was $80.8 million, surpassing the estimated $75.14 million [4] - Operating Profit for Advanced Healthcare Solutions was $39.1 million, above the average estimate of $36.77 million [4] - Operating Profit for Intelligent Operating Solutions was $166.7 million, below the average estimate of $179.96 million [4] - Operating Profit for Other segments was -$76.8 million, significantly worse than the average estimate of -$30.83 million [4] Stock Performance - Fortive's shares have returned -4.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of +3.4% [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Fortive reported revenue of $1.47 billion for the quarter ended March 2025, a decrease of 3.3% year-over-year, and EPS of $0.85, slightly up from $0.83 in the previous year [1] - The revenue fell short of the Zacks Consensus Estimate of $1.49 billion, resulting in a surprise of -1.22%, while the EPS met the consensus estimate [1] Financial Performance Metrics - Sales in Intelligent Operating Solutions reached $671.40 million, exceeding the estimated $669.35 million, reflecting a year-over-year increase of 0.9% [4] - Sales in Advanced Healthcare Solutions were $302.20 million, slightly below the estimated $303.14 million, with a year-over-year increase of 0.8% [4] - Sales in Precision Technologies were reported at $500.60 million, significantly lower than the estimated $524.46 million, marking a year-over-year decline of 10.5% [4] - Operating profit for Precision Technologies was $87.30 million, below the average estimate of $98.49 million [4] - Operating profit for Intelligent Operating Solutions was $173.70 million, surpassing the estimated $158.96 million [4] - Operating profit for Advanced Healthcare Solutions was $26.30 million, exceeding the average estimate of $24.60 million [4] - Adjusted operating profit (Non-GAAP) for Advanced Healthcare Solutions was $70.90 million, below the estimate of $74.55 million [4] - Adjusted operating profit (Non-GAAP) for Intelligent Operating Solutions was $223.70 million, above the estimate of $211.49 million [4] - Adjusted operating profit (Non-GAAP) for Precision Technologies was $109.10 million, below the average estimate of $122.67 million [4] - Operating profit for Other segments was reported at -$53.70 million, worse than the estimated -$36.23 million [4] Stock Performance - Fortive's shares have returned -6.2% over the past month, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]